Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD.

This study provides new insight into the diagnostic and prognostic capability of neutrophil and eosinophil biomarkers in IBD and suggests that MPO, alone or in combination with FC, may add to the diagnostic power of faecal biomarkers.